Hypoxia-inducible factor-2α (HIF-2α) induces angiogenesis in breast carcinomas

被引:37
作者
Giatromanolaki, A
Sivridis, E
Fiska, A
Koukourakis, MI
机构
[1] Democritus Univ Thrace, Dept Pathol, Sch Med, Alexandroupolis, Greece
[2] Democritus Univ Thrace, Dept Anat, Sch Med, Alexandroupolis, Greece
[3] Democritus Univ Thrace, Dept Radiotherapy Oncol, Sch Med, Alexandroupolis, Greece
关键词
hypoxia-inducible factor-2 alpha; angiogenesis; c-erbB-2; metastasis; breast carcinomas;
D O I
10.1097/01.pai.0000145182.98577.10
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Hypoxia-inducible factors-1 alpha (HIF-1 alpha) and HIF-2 alpha are important proteins initiating tumor cell responses to hypoxia. Specifically, the transcription of genes related to erythropoiesis, glycolysis, and angiogenesis depends on the rate of HIF alpha binding to DNA at the hypoxia response elements of target genes. In this study, the authors evaluated the immunohistochemical expression of HIF-2 alpha in 62 infiltrating ductal carcinomas of the breast, not otherwise specified, in relation to estrogen and progesterone receptors, the MIB1 proliferation index, the vascular density, and the proteins c-erbB-2, bcl-2, and p53. Extensive and strong cytoplasmic and/or nuclear expression of HIF-2 alpha was noted in 23 of the 64 (35.9%) cases, and this was associated with increased vascular density (P = 0.0002), increased c-erbB-2 membrane expression (P = 0.02), and secondary deposits to multiple axillary lymph nodes (> 3). In multivariate analysis, HIF-2 alpha and T stage were the only variables related to extensive nodal metastasis. The authors conclude that HIF-2 alpha overexpression, a common event in infiltrating ductal carcinomas of the breast, is related to high metastatic potential via increased angiogenic and c-erbB-2 activity.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 29 条
[1]  
Akakura N, 2001, CANCER RES, V61, P6548
[2]   Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma [J].
Bos, R ;
van der Groep, P ;
Greijer, AE ;
Shvarts, A ;
Meijer, S ;
Pinedo, HM ;
Semenza, GL ;
van Diest, PJ ;
van der Wall, E .
CANCER, 2003, 97 (06) :1573-1581
[3]   Hypoxia-inducible factor-2α (HIF-2α) is involved in the apoptotic response to hypoglycemia but not to hypoxia [J].
Brusselmans, K ;
Bono, F ;
Maxwell, P ;
Dor, Y ;
Dewerchin, M ;
Collen, D ;
Herbert, JM ;
Carmeliet, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :39192-39196
[4]   A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regulates the VEGF expression and is potentially involved in lung and vascular development [J].
Ema, M ;
Taya, S ;
Yokotani, N ;
Sogawa, K ;
Matsuda, Y ;
FujiiKuriyama, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4273-4278
[5]  
Feldser D, 1999, CANCER RES, V59, P3915
[6]   OXYGEN DISTRIBUTION IN SQUAMOUS-CELL CARCINOMA METASTASES AND ITS RELATIONSHIP TO OUTCOME OF RADIATION-THERAPY [J].
GATENBY, RA ;
KESSLER, HB ;
ROSENBLUM, JS ;
COIA, LR ;
MOLDOFSKY, PJ ;
HARTZ, WH ;
BRODER, GJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (05) :831-838
[7]   Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin [J].
Giatromanolaki, A ;
Sivridis, E ;
Kouskoukis, C ;
Gatter, KC ;
Harris, AL ;
Koukourakis, MI .
MELANOMA RESEARCH, 2003, 13 (05) :493-501
[8]  
Giatromanolaki A, 2001, ANTICANCER RES, V21, P4317
[9]   Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival [J].
Giatromanolaki, A ;
Koukourakis, MI ;
Sivridis, E ;
Turley, H ;
Talks, K ;
Pezzella, F ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 2001, 85 (06) :881-890
[10]   Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? [J].
Gruber, G ;
Greiner, RH ;
Hlushchuk, R ;
Aebersold, DM ;
Altermatt, HJ ;
Berclaz, G ;
Djonov, V .
BREAST CANCER RESEARCH, 2004, 6 (03) :R191-R198